Myeloprotection with trilaciclib in Chinese patients with extensive-stage small cell lung cancer receiving chemotherapy: Results from a randomized, double-blind, placebo-controlled phase III study (TRACES)

Ying Cheng, Lin Wu, Dingzhi Huang, Qiming Wang, Yun Fan, XiQin Zhang, Huijie Fan, WenXiu Yao, Baogang Liu, Guohua Yu, Yueyin Pan, Fei Xu, Zhiyong He, Xiaorong Dong, Rui Ma, Xuhong Min, X. Ge, Hualin Chen, Qun Liu, Yanping Hu, Ying Liu, Yang Chen, Yang Yang, Xiucui Li, Li Zhou